GREY:ICOTF - Post by User
Post by
DrHolidayon Jul 01, 2018 1:49pm
271 Views
Post# 28257320
Proper due diligence and research
Proper due diligence and research
Thank you for these contributions, Croptimal & gainwidpatience:
Anyone who sold recently ought to read this write up by doublebank in bold, because the timing is right to buy ICO.
Looking forward to July news on 2 fronts, Oral B Amphotericin and Bertilimumab (iCo-008).
It is quite clear to me that buyers last week were picking the pockets of sellers who have failed to do their proper due diligence and research. Smart traders who scalped the stock around the 20 cent level and re-purchased anywhere from .115 to .155 would be smart to hold on for the big rally. As I have stated before, timing is often the key to successful investing and trading, and ICO is telling us what to expect in July. AstraZeneca, Mediummune and Salvat and other company alliances are a very positive endorsement. ICO is in play for a potential takeover by big pharma.
Now is the time to throw long and to add to your positions and buy on strength. Go long for a touchdown in football parlance. Any BLOCKBUSTER PRESS will require a trading halt.
I have not sold a single share, and I wish I had more capital available to triiple or quadruple up on ICO here. When ICO vaults into the stratoshpere, I expect much wailing and weeping by sellers on this board who had sold way too early.
https://www.doublebank.ca/ico-info.html
https://www.icotherapeutics.com/_resources/news/nr_June_12_2017.pdf
https://www.icotherapeutics.com/_resources/news/nr_June_15_2017.pdf
https://www.icotherapeutics.com/newsroom/2015/index.php?content_id=225
Review all past news releases here on this page:
https://www.icotherapeutics.com/newsroom/
DOC.